Given the importance of this document in setting the framework for the eventual Purchase Agreement at the end of a Due Diligence process, it is vital that sellers involve an experienced attorney in the review process, as part of their larger transaction team. A qualified attorney’s involvement and review can ensure that the letter of intent is detailed enough to serve as a solid template for the final agreement, affords the proper protections in place for their client, and ultimately, significantly increasing the likelihood of a successful sale.

Understanding the Role of a Letter of Intent in Healthcare M&A

A LOI outlines the main terms a buyer is proposing to the selling ownership, laying the foundation for a due diligence process. Though often referred to as a “non-binding” agreement, meaning either party can terminate the contract at their discretion, certain elements, like confidentiality and exclusivity clauses, are binding. These clauses protect both parties and ensure the seriousness of the negotiations and coming due diligence process.

For buyers, a signed LOI signifies the seller’s commitment to the deal, making it worthwhile to commence due diligence. For sellers, the LOI triggers the process of populating a data room with the necessary information requested from a particular buyer. Signing the LOI also helps reduce legal costs long-term, as a detailed purchase agreement is only prepared after crucial terms have been agreed upon in the letter of intent. Negotiating the LOI may uncover issues that need resolution before or during due diligence, increasing the likelihood of a successful sale.

Price & Type of Transaction: Asset vs. Stock Purchase

An LOI specifies the price and high-level terms, including the structure of the deal—whether it will be an asset purchase or stock purchase, two of the most common structures in middle-market M&A.

In an asset purchase, the buyer acquires specific assets and liabilities, allowing them to assume only the associated risks, such as equipment, licenses, and accounts payable. Once the sale is completed, these assets and liabilities are transferred to the buyer, staff is hired on by the new organization, and the seller typically closes out their business. 

A stock purchase, on the other hand, involves the buyer purchasing the entire company, including all assets and liabilities. This is often a simpler transaction since it does not require selecting specific assets to purchase. 

Additionally, the structure of the purchase—whether asset or stock—has significant tax implications. Asset purchases may result in higher tax liabilities for the seller but offer potential tax benefits for the buyer due to depreciation. Conversely, stock purchases might be more tax-efficient for the seller, as they often result in capital gains taxation, which could be at a lower rate. Therefore, it’s essential to consult with tax advisors to fully understand the tax consequences of each transaction type.

A critical aspect of the letter of intent is understanding how the buyer arrives at the offered value. This typically involves financial metrics such as EBITDA, revenue multiples, or asset valuation. The buyer’s methodology should be transparent, allowing the seller to understand the basis for the proposed price, typically in the form of a multiple of a particular financial metric. Most common in middle-market healthcare M&A is a multiple of EBITDA, although other metrics can be utilized depending on the segment of healthcare.

Working Capital in the LOI: Definition, Calculation, and Strategic Considerations

In healthcare M&A deals, net working capital (WC) is a crucial component, calculated by subtracting current liabilities from current assets. This metric represents the capital required to keep the business operational. However, the calculation can become complex depending on the specifics of the business and the deal structure.

Buyers often include a net working capital target, or "peg," in the LOI to ensure there is sufficient working capital to run the business effectively post-acquisition. This target sets a baseline amount of working capital that the buyer expects to be available at the time of closing. If the actual working capital falls short of the target, the purchase price may be adjusted downward. Conversely, if the working capital exceeds the target, the buyer may be required to provide additional compensation.

The treatment of working capital can vary depending on the type of buyer. Private Equity Groups (PEGs) typically require a firm working capital peg, ensuring the business can sustain itself financially post-acquisition. Strategic buyers, however, may be more flexible, potentially negotiating or even eliminating the working capital requirement based on how the acquisition fits into their broader goals.

For sellers, understanding and negotiating the working capital terms is critical. Failing to meet the agreed-upon target can lead to a reduction in the final sale price, while exceeding the target might benefit the seller financially. It’s crucial to work with financial advisors to clearly define and negotiate the working capital terms in the letter of intent.

Setting Exclusivity and Timeline for Closing

Exclusivity and the closing timeline are critical components outlined in the LOI. Exclusivity means the seller agrees to negotiate solely with the buyer for a specified period, preventing engagement with other potential buyers. This clause also restricts the seller from sharing M&A details with other parties, ensuring that the negotiations remain focused and confidential.

The closing timeline typically follows the finalization of negotiations and the agreement on key documents like the Purchase Agreement. At closing, the buyer pays the purchase amount, and assets, stocks, or other financial instruments are transferred.

It is essential to ensure that a target closing date is explicitly stated in the LOI. While 90-120 days is the market standard for closing, it's prudent to anticipate that the deal may take longer, especially given the complexities of regulatory approvals in the healthcare industry. These potential delays should be acknowledged and discussed in the LOI to maintain transparency and set realistic expectations for both parties.

Representations and Warranties: Minimizing Negotiation Through Detail

Representations and warranties (reps and warranties) are the seller’s disclosures to the buyer, intended to protect the buyer from certain risks. For example, if the seller claims all taxes are paid, but the buyer discovers unpaid taxes post-sale, the buyer may have grounds to rescind the contract or seek damages.

Adverse covenant provisions may also be included, prohibiting the seller from making significant business changes between signing the Purchase Agreement and closing. This could involve restrictions on entering new service agreements or altering employee compensation.

Warranties assure the buyer that the seller’s claims are accurate and protect against financial, operational, or legal harm if they are not. The indemnification clause in the LOI outlines the consequences of breaching warranties, such as awarding damages to the buyer. The more detail included in these disclosures, the less there will be to negotiate during the due diligence process, leading to a smoother transaction.

Non-Compete Agreements and Employment Terms

Non-compete and employment agreements are critical components in LOIs. These agreements help ensure the buyer's success post-transaction by preventing key leaders in the seller’s company from competing with or interfering in the buyer’s business after the sale.

The LOI includes protective covenants, such as non-compete, confidentiality, non-solicitation of employees, and non-solicitation of customers and vendors. Employment agreements may also be included when the buyer requires the continued employment of key personnel who are crucial to operations and maintain valued customer relationships.

Additional Considerations to Include in the LOI

In healthcare M&A, the essential components of an LOI are just the starting point. Additional details should be addressed between a prospective buyer and seller to create a robust and clear agreement, minimizing the risk of misunderstandings and ensuring a greater chance of a smooth transaction process. These considerations can vary based on the unique characteristics of the business being acquired.

In addition to the items above, we typically require the following be addressed in LOIs:

• Overview of the Buying Company and Healthcare Investment Thesis: A description of the buying company’s background and their strategic rationale for investing in healthcare, including how the target business fits into their current portfolio or platform.
• Source of Funds and Acquisition Structure: Details on the buyer’s source of funds and how they plan to structure the acquisition, including any lenders or banks involved.
• Ownership Involvement Post-Acquisition: How the buyer envisions the current ownership’s involvement, if any, through the transition period.
• Working Capital Requirements: Specifics on working capital requirements, if applicable, and how they will be managed.
• Insurance Coverage Needs: Requirements for tail insurance coverage and/or representations and warranties insurance to cover potential liabilities.
• Due Diligence Firms: Identification of the firms engaged for due diligence, including legal, operational, clinical, and quality-of-earnings specialists.
• Timeline and Exclusivity: A timeline for due diligence and closing, with a proposed exclusivity period and target closing date.
• Purchase Price Consideration: Details on how the purchase price was determined and any specific considerations related to the price.
• Holdback Amount: If applicable, the LOI should outline any holdback amount and overview of standard reps and warranties.
• Equity Offerings: If equity is being offered or rolled over, provide a cap table and framework of the subscription agreement.
• On-Site Visit Requirements: Any requirements for on-site visits should be specified.

It’s also crucial to clarify who will bear the expenses and professional fees for legal, accounting, and banking services. For example, if the buyer files an HSR Form before signing a purchase agreement, they should cover the associated costs.

Other potential considerations include whether the buyer will have access to employees and customers or whether the sale is contingent on government approvals. By addressing all these elements in the LOI, the parties can set clear expectations and reduce the likelihood of complications during the transaction process.

Increasing the Likelihood of a Successful Transaction

The careful inclusion and negotiation of LOI components in healthcare transactions are key to successfully completing the deal. Given the complexity of these factors, sellers should not navigate this process without experienced M&A support. Missteps in the LOI stage can lead to costly errors, extended timelines, or a reduced sale price.

While an LOI is mostly non-binding, it’s packed with business and legal terms that carry significant implications. Understanding these details is crucial to avoiding negative consequences. Successful LOI negotiations lay the groundwork for a smooth transition to the Purchase Agreement and, ultimately, a successful sale.

M&A Healthcare Advisors, an Investment Bank providing M&A advisory services, brings expertise, experience, and knowledge to each transaction, driving value for the seller. Contact us to discuss how we can make your selling journey seamless and successful.